NCT00427583View on ClinicalTrials.gov

Imatinib Mesylate Treatment of Patients With Malignant Peripheral Nerve Sheath Tumors

PHASE2/PHASE3TerminatedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

April 30, 2009

Conditions
Malignant Peripheral Nerve Sheath Tumors
Interventions
DRUG

imatinib mesylate

Trial Locations (2)

Unknown

Novartis Investigative Site, Berlin

Novartis Investigative Site, Hamburg

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY